{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:07:14Z","timestamp":1793689634204,"version":"4.5.1"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>\n                    Herein, we present a case of a patient with intrahepatic cholangiocarcinoma (ICC) who underwent [\n                    <jats:sup>18<\/jats:sup>\n                    F]FDG, [\n                    <jats:sup>68<\/jats:sup>\n                    Ga]Ga-Trivehexin, and [\n                    <jats:sup>68<\/jats:sup>\n                    Ga]Ga-FAPI-04 PET\/CT scans for initial staging. The primary liver lesion demonstrates progressively increased uptake across all 3 tracers, whereas metastatic cervical lymph nodes are visualized with [\n                    <jats:sup>68<\/jats:sup>\n                    Ga]Ga-FAPI-04 PET\/CT and [\n                    <jats:sup>68<\/jats:sup>\n                    Ga]Ga-Trivehexin but not with [\n                    <jats:sup>18<\/jats:sup>\n                    F]FDG; importantly, [\n                    <jats:sup>68<\/jats:sup>\n                    Ga]Ga-FAPI-04 PET\/CT, in addition, delineates metastatic abdominal lymph nodes. This case highlights that [\n                    <jats:sup>68<\/jats:sup>\n                    Ga]Ga-Trivehexin PET\/CT may serve as an alternative to [\n                    <jats:sup>18<\/jats:sup>\n                    F]FDG PET\/CT, warranting reevaluation of FDG limitations, while FAPI remains a strong competitor to both.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006310","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:01:20Z","timestamp":1770044480000},"page":"e657-e658","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Optimizing Intrahepatic Cholangiocarcinoma Staging"],"prefix":"10.1097","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8270-9480","authenticated-orcid":false,"given":"Dilara","family":"Denizmen Zorba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilsat Firat","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Sanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Kuyumcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"R1-20260702","doi-asserted-by":"crossref","first-page":"789","DOI":"10.21037\/hbsn-22-273","article-title":"(18)F-fluorodeoxyglucose positron emission tomography for intrahepatic cholangiocarcinoma N- and M-staging: should guidelines recommend it at last?","volume":"11","author":"Zizzo","year":"2022","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R2-20260702","doi-asserted-by":"crossref","first-page":"758958","DOI":"10.3389\/fonc.2021.758958","article-title":"Fibroblast-activated protein inhibitor PET\/CT: cancer diagnosis and management","volume":"11","author":"Kuyumcu","year":"2021","journal-title":"Front Oncol"},{"key":"R3-20260702","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2967\/jnumed.122.265215","article-title":"Superior tumor detection for (68)Ga-FAPI-46 versus (18)F-FDG PET\/CT and conventional CT in patients with cholangiocarcinoma","volume":"64","author":"Pabst","year":"2023","journal-title":"J Nucl Med"},{"key":"R4-20260702","doi-asserted-by":"crossref","first-page":"15330338231189399","DOI":"10.1177\/15330338231189399","article-title":"Review and application of integrin alpha v beta 6 in the diagnosis and treatment of cholangiocarcinoma and pancreatic ductal adenocarcinoma","volume":"22","author":"Lian","year":"2023","journal-title":"Technology in Cancer Research & Treatment"},{"key":"R5-20260702","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1007\/s00259-021-05443-8","article-title":"PET\/CT imaging of pancreatic carcinoma targeting the \u201ccancer integrin\u201d alphavbeta6","volume":"48","author":"Quigley","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R6-20260702","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/RLU.0000000000005278","article-title":"Potential efficacy of 68 Ga-Trivehexin PET\/CT and immunohistochemical validation of \u03b1v\u03b26 integrin expression in patients with head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma","volume":"49","author":"Das","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R7-20260702","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/RLU.0000000000005406","article-title":"68 Ga-Trivehexin PET\/CT in metastatic non-small cell lung cancer to the brain","volume":"49","author":"Marafi","year":"2024","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006310","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:03:41Z","timestamp":1783022621000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006310"}},"subtitle":["Comparison of [18F]FDG, [68Ga]Ga-FAPI, and [68Ga]Ga-Trivehexin PET\/CT Imaging"],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":7,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006310","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"2025-09-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}